bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
etesevimab (JS016) - Chinese Academy of Sciences, Shanghai Junshi Biosci, Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/36940010
 
Mar 21, 2023
 
Prev Next